⭐ Start off 2025 with a powerful boost to your portfolio: January’s freshest AI-picked sharesUnlock shares

European shares open lower before ECB meeting

Published 14/06/2018, 10:02
© Reuters. A man talks on a phone at the Madrid stock exchange which plummeted after Britain voted to leave the European Union in the EU BREXIT referendum, in Madrid
UK100
-
DE40
-
RIO
-
GSK
-
BHPB
-
RR
-
AVV
-
HG
-
GLEN
-
GLJn
-
VOWG_p
-
STOXX
-
SXPP
-

By Danilo Masoni

MILAN (Reuters) - European shares fell on Thursday in cautious trade after the U.S. Federal Reserve sounded slightly hawkish overnight and ahead of a European Central Bank meeting at which it will debate the end of its huge asset purchases.

By 0812 GMT, the pan-European STOXX 600 (STOXX) index was down 0.5 percent, while Britain's FTSE (FTSE) was down 0.5 percent and Germany's DAX (GDAXI) fell 0.4 percent.

The European Central Bank will debate whether to end its huge asset purchases by year-end, in what would be its biggest step towards dismantling crisis-era stimulus credited with pulling the euro zone economy out of recession.

Some investors said they did not expect the ECB to announce any decision on Thursday but rather wait for the July meeting to better asses the impact of an economic slowdown in the region.

"Once again ECB President Mario Draghi will have to be at his dextrous best at buying the ECB time when it comes to verbalising the likely differing opinions on the timing of an exit strategy... given current weakness in some of the recent data," said Michael Hewson, analyst at CMC Markets.

All sectors traded in negative territory with basic resources stocks (SXPP), down 1.6 percent, leading the fall following weaker-than-expected data from big metals consumer China that sent copper prices near one-week lows.

Shares in miners Glencore (L:GLEN) , Rio Tinto (L:RIO) and BHP Billiton (L:BLT) fell between 1.6 and 2.4 percent.

Bucking the broader weakness were shares in heavyweight drugmaker GSK (L:GSK), up 0.8 percent. Investors welcomed news that its two-drug treatment for HIV met its main goal in late stage studies - a big win after regulators warned of possible birth defects from one of the two drugs.

Rolls-Royce (L:RR) was another bright spot, up 2.7 percent, after saying it would save 400 million pounds a year by cutting 4,600 jobs in its latest attempt to simplify the business and generate more cash.

"After spending around four and half years in purdah, an incremental £400 million of FCF (free cash flow)would allow Rolls-Royce to take a significant step toward meeting its financial targets," Jefferies analysts said.

"That should then mean Rolls-Royce can make an adequate annual return to shareholders through the dividend," they added.

Aveva (L:AVV) was the biggest gainer on the STOXX, up 11.9 percent to a record high after strong results from the British engineering software company.

On the DAX, Volkswagen (DE:VOWG_p) fell 0.4 percent after the carmaker was fined one billion euros over diesel emissions cheating.

© Reuters. A man talks on a phone at the Madrid stock exchange which plummeted after Britain voted to leave the European Union in the EU BREXIT referendum, in Madrid

Still in Germany, leasing company Grenke (DE:GLJn) announced a cash capital increase of up to 200 million euros. Its shares were among the leading losers on the STOXX, down 5.7 percent.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.